Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,331
Closed -$294K 45
2024
Q2
$294K Buy
7,331
+440
+6% +$21.1K 0.2% 16
2024
Q1
$364K Buy
+6,891
New +$706K 0.21% 15
2022
Q4
Sell
-980
Closed -$244K 112
2022
Q3
$244K Sell
980
-5,294
-84% -$1.26M 0.31% 57
2022
Q2
$910K Buy
6,274
+145
+2% +$43.5K 0.62% 32
2022
Q1
$2.89M Sell
6,129
-353
-5% -$130K 0.43% 14
2021
Q4
$2.92M Buy
6,482
+1,433
+28% +$828K 0.42% 35
2021
Q3
$3.38M Buy
+5,049
New +$5.41M 0.46% 30

Other funds holding BIVI

Sabby Management's BIVI Position: Q3 2024 in Review

Sabby Management sold out of BioVie (BIVI) in Q3 2024, closing a stake of 7,331 shares — an estimated $294K sold.

Sabby Management first reported a position in BIVI in Q3 2021 and held it in 7 quarters. The position peaked at $3.38M in Q3 2021. 25 funds tracked by Wall St. Rank hold BIVI as of Q3 2024.

  • Sabby Management reported no remaining BioVie position as of Q3 2024 after selling out during the quarter.
  • Sabby Management sold 7,331 BioVie shares in Q3 2024, an estimated $294K.
  • Sabby Management first reported a position in BioVie in Q3 2021 and held it in 7 quarters.
  • Sabby Management's BioVie position peaked at $3.38M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held BioVie as of Q3 2024.

Based on Sabby Management's 13F filing for Q3 2024, filed 14 Nov 2024.